Literature DB >> 17141753

Investigation of the functional roles of the MELAL and GQXXRXG motifs of the human noradrenaline transporter using cysteine mutants.

Sonja Sucic1, Lesley J Bryan-Lluka.   

Abstract

The study examines the roles of the highly conserved MELAL and GQXXRXG motifs, located in the second transmembrane domain and the first intracellular loop of the human noradrenaline transporter (hNET). We have previously shown that this region does not directly participate in the NET substrate translocation pathway [Sucic, S., and Bryan-Lluka, L.J., 2005. Roles of transmembrane domain 2 and the first intracellular loop in human noradrenaline transporter function: pharmacological and SCAM analysis. J. Neurochem. 94, 1620-1630.], while the current report focuses on the importance of this region in determining other functional properties of the hNET. Mutation to cysteine of the wild-type residues was carried out by site-directed mutagenesis of hNET cDNA. The wild-type and mutant hNETs were expressed in transiently transfected COS-7 cells and the effects of these mutations were pharmacologically examined. The results indicate that the GQXXRXG motif is important for the binding of cocaine, but not antidepressants. The hN120C mutant caused an 11-fold increase in the binding affinity of cocaine, compared to the wild-type hNET, while hQ118C, hY119C, hR121C and hE122C showed smaller increases. Interestingly, the apparent affinities of cocaine for some of these mutants were either decreased or unchanged, contrasting with the effects observed from the binding studies. The hE113C mutant in the MELAL motif caused very marked (over 400-fold) reductions in the binding affinities of substrates, but had no effects on the binding affinities of cocaine or antidepressants. Overall, the MELAL and GQXXRXG motifs are important determinants of NET cell surface expression and substrate and inhibitor binding. The results further suggest that the binding sites for substrates, cocaine and antidepressants on the NET are distinct but overlapping.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17141753     DOI: 10.1016/j.ejphar.2006.10.058

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  5 in total

1.  The N terminus of monoamine transporters is a lever required for the action of amphetamines.

Authors:  Sonja Sucic; Stefan Dallinger; Barbara Zdrazil; René Weissensteiner; Trine N Jørgensen; Marion Holy; Oliver Kudlacek; Stefan Seidel; Joo Hwan Cha; Ulrik Gether; Amy H Newman; Gerhard F Ecker; Michael Freissmuth; Harald H Sitte
Journal:  J Biol Chem       Date:  2010-01-29       Impact factor: 5.157

2.  Extracellular loop 3 of the noradrenaline transporter contributes to substrate and inhibitor selectivity.

Authors:  Timothy Lynagh; Tina S Khamu; Lesley J Bryan-Lluka
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-10-01       Impact factor: 3.000

3.  Functional Rescue of a Misfolded Drosophila melanogaster Dopamine Transporter Mutant Associated with a Sleepless Phenotype by Pharmacological Chaperones.

Authors:  Ameya Kasture; Ali El-Kasaby; Daniel Szöllősi; H M Mazhar Asjad; Alexandra Grimm; Thomas Stockner; Thomas Hummel; Michael Freissmuth; Sonja Sucic
Journal:  J Biol Chem       Date:  2016-08-01       Impact factor: 5.157

4.  When transporters fail to be transported: how to rescue folding-deficient SLC6 transporters.

Authors:  Sonja Sucic; Ameya Kasture; H M Mazhar Asjad; Carina Kern; Ali El-Kasaby; Michael Freissmuth
Journal:  J Neurol Neuromedicine       Date:  2016-12-30

5.  Structure Modeling of the Norepinephrine Transporter.

Authors:  Izabella Góral; Kamil Łątka; Marek Bajda
Journal:  Biomolecules       Date:  2020-01-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.